Genome Editing in Human iPS Cells to Study and Cure Disease
Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More
News
2026. 5. 1. Takako Ishiwatari joins the lab as a research assistant.
2026. 4. 13. Yamaha Motor's CELL HANDLER User's Voice is out.
2026. 4. 1. Miyu Kinoshita and Hiroto Serita join the lab as graduate students!
2026. 3. 30. Lanyu Huang is awarded the Belle Foundation Fellowship!!
2026. 1. 1. Sonoko Matsumoto joins the lab as an Intern!
2026. 1. 1. The 10th Anniversary of the Lab!
2025. 12. 26. Kayoko Shinozaki is selected as a JSPS Fellow (DC1)!!
2025. 12. 16. Lanyu Huang wins the 2025 MBSJ Poster Award!
2025. 12. 1. Yuka Satake joins the lab as an Intern!
2025. 10. 22. Ittetsu Nakajima wins the best presentation award in the Institutional poster presentation competition.
2025. 10. 1. Shana Shiikawa joins the lab as an Intern!
Upcoming
2026. 6. 21-25. Cold Spring Harbor Asia Alzheimer's Disease and related disorders Meeting in Awaji Island (Yuga Yasuda and Tomoko Kato presenting).
2026. 7. 23-25. The 32nd Annual Meeting of Japan Society of Gene and Cell Therapy in Osaka (Kayoko Shinozaki presenting).
2026. 12. Seminar at Ome Nursing School